Literature DB >> 11264160

Erythroblasts are a source of angiogenic factors.

R Tordjman1, S Delaire, J Plouët, S Ting, P Gaulard, S Fichelson, P H Roméo, V Lemarchandel.   

Abstract

In adult bone marrow, mature erythroblasts are produced within structures called erythroblastic islands and then cross the endothelial barrier to reach circulation. Erythroblastic islands are composed of a central macrophage surrounded by maturing erythroblasts. In this study, it is shown that erythroid cells, but not the other mature hematopoietic cells, coexpress 2 angiogenic factors, vascular endothelial growth factor A (VEGF-A) and placenta growth factor (PlGF). Secretion of both VEGF-A and PlGF increases during in vitro erythroid differentiation. Erythroblast-conditioned medium can induce both migration of monocytes and endothelial cells and the permeability of endothelial cells. These effects are inhibited by anti-PlGF and/or anti-VEGF antibodies. Finally, it is shown that VEGF-A and PlGF proteins are expressed by bone marrow erythroblasts in vivo. Angiogenic factors secreted by erythroblasts may promote interactions either with macrophages in erythroblastic islands or with endothelial cells that would facilitate the passage of erythroid cells through the endothelial barrier. (Blood. 2001;97:1968-1974)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11264160     DOI: 10.1182/blood.v97.7.1968

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

Review 1.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.

Authors:  Caryn S Gonsalves; Chen Li; Marthe-Sandrine Eiymo Mwa Mpollo; Vinod Pullarkat; Punam Malik; Stanley M Tahara; Vijay K Kalra
Journal:  Biochem J       Date:  2015-04-16       Impact factor: 3.857

3.  EKLF and KLF2 have compensatory roles in embryonic beta-globin gene expression and primitive erythropoiesis.

Authors:  Priyadarshi Basu; Tina K Lung; Wafaa Lemsaddek; Thanh Giang Sargent; David C Williams; Mohua Basu; Latasha C Redmond; Jerry B Lingrel; Jack L Haar; Joyce A Lloyd
Journal:  Blood       Date:  2007-08-03       Impact factor: 22.113

Review 4.  The erythroblastic island.

Authors:  Deepa Manwani; James J Bieker
Journal:  Curr Top Dev Biol       Date:  2008       Impact factor: 4.897

5.  Muscle satellite cells and endothelial cells: close neighbors and privileged partners.

Authors:  Christo Christov; Fabrice Chrétien; Rana Abou-Khalil; Guillaume Bassez; Grégoire Vallet; François-Jérôme Authier; Yann Bassaglia; Vasily Shinin; Shahragim Tajbakhsh; Bénédicte Chazaud; Romain K Gherardi
Journal:  Mol Biol Cell       Date:  2007-02-07       Impact factor: 4.138

Review 6.  Erythroblastic islands: niches for erythropoiesis.

Authors:  Joel Anne Chasis; Narla Mohandas
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

Review 7.  Placental growth factor: What hematologists need to know.

Authors:  Laura F Newell; Shernan G Holtan
Journal:  Blood Rev       Date:  2016-08-27       Impact factor: 8.250

8.  MicroRNA 648 Targets ET-1 mRNA and is cotranscriptionally regulated with MICAL3 by PAX5.

Authors:  Chen Li; Caryn S Gonsalves; Marthe-Sandrine Eiymo Mwa Mpollo; Punam Malik; Stanley M Tahara; Vijay K Kalra
Journal:  Mol Cell Biol       Date:  2014-11-17       Impact factor: 4.272

Review 9.  Placenta growth factor mediated gene regulation in sickle cell disease.

Authors:  Vijay K Kalra; Shuxiao Zhang; Punam Malik; Stanley M Tahara
Journal:  Blood Rev       Date:  2017-08-16       Impact factor: 8.250

10.  Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells.

Authors:  Nitin Patel; Stanley M Tahara; Punam Malik; Vijay K Kalra
Journal:  Biochem J       Date:  2011-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.